Supplier of Premium Ingredients to the Food, Nutritional & Personal Care Industries

ILDONG_LOGO_MASTER_smwprobiotics
probiotics_head

Over 80 Years of Probiotic Expertise

As the leading name in probiotic innovation in South Korea, Ildong Bioscience has been researching probiotics and probiotic fermentation technology for over 80 years.

PROBIOTICS

qshieldtm
  • Enhanced Stability
  • Proven Safety
  • Excellent Efficacy
  • quad-coatingball450

    STABILITY ENHANCED PROBIOTICS USING QUADRUPLE-COATED TECHNOLOGY

    Nutralliance has partnered with Ildong Bioscience to bring their patented quadruple-coated strains to North America in turnkey probiotic solutions or fully customized offerings. Ildong Bioscience features a wide selection of strains that provide tangible health benefits with scientific documentation while meeting regulatory demands.

    Bacillus subtitls IDCC 1101

    Bacillus coagulans IDCC 1201

    Enterococcus faecium IDCC 2102

    Streptococcus thermophilus IDCC 2201

    Lactoccocus lactis IDCC 2301

    Lactobacillus gasseri IDCC 3101

    Lacticaseibacillus rhamnosus IDCC 3201

    Lactobacillus acidophilus IDCC 3302

    Lacticaseibacillus paracasei IDCC 3401

    Lacticaseibacillus casei IDCC 3451

    Lactiplantibacillus plantarum IDCC 3501

    Ligilactoctobacillus salivarius IDCC 3551

    Lactobacillus bulgaricus IDCC 3601

    Limosilactobacillus reuteri IDCC 3701

    Lactobacillus helveticus IDCC 3801

    Limosilactobacillus fermentum IDCC 3901

    Bifidobacterium longum IDCC 4101

    Bifidobacterium bifidum IDCC 4201

    Bifidobacterium lactis IDCC 4301

    Bifidobacterium breve IDCC 4401

    Lactobacillus johnsonii IDCC 9203

    BiogenFinalistBLactis500
    JPL934logo

    Lactiplantibacillus plantarum IDCC 3501

    Bifidobacterium lactis IDCC 4301

    Lactobacillus johnsonii IDCC 9203

    Clinically Proven Probiotics Blend which can improve bowel movement, gut health, and lower gastrointestinal symptoms.

    ​Its efficacy has been proven through a wide range of clinical tests, including in vitro, in vivo, and human.​

    SPORES

    SporableLogo2
  • GRAS Approved
  • Exceptional Thermal Stability
  • Ildong's Patented Production Technology
  • SPORABLE is the trademark of B. coagulans IDCC 1201 made by ILDONG BIOSCIENCE, which started its first probiotics career with SPORABLE in 1949.

    Currently, ILDONG is producing the highest concentration of B. coagulans and its functionality, safety, and stability are being proven through SCI-indexed publications, Patents, and experiments by the IBS research center.

    POSTBIOTICS

    ceraglow_logo_275px

    What is Cera-Glow?

    A patented Lacticaseibacillus rhamnosus Lysate preparation, made to enhance skin barrier function by increasing ceramide content, an essential component of healthy skin.

    ceraglowgirlweb

    Cera-Glow enhances ceramide production in human epidermal keratinocytes by stimulating sphingomyelinase activity.

    postbioticsWebGraphic

    RHT3201 provides formulation stability without stability concerns

    • Chewable Tablets
    • Capsules
    • Powders
    • Gummies
    • Stick Jelly
    • Soft Gels

    The goal of RHT3201™ is to maintain a balanced immunological response in human bodies which is essential as excessive immunological responses can cause hypersensitivity reactions.

    ​Through several studies, RHT3201™ has shown significant effects on the production of cytokines and helps to modulate the balanced immune response between Th1 and Th2. These immunomodulatory effects lead to the suppression of hypersensitivity reactions.

    ​Enjoy immune health and gut health with the very newest ingredients.

    Screenshot 2024-01-16 at 40717 PM

    A New Era in Cholesterol Parabiotics

    Screenshot 2024-01-16 at 34134 PM

    ILDONG Bioscience introduces BBR4401, a novel parabiotic recognized by Korea's KFDA for its innovative approach to health. Harnessing the power of Bifidobacterium breve IDCC 4401, this product stands at the forefront of cholesterol and gut health management.

    Exploring the Study
    Delve into the groundbreaking clinical trial of BBR4401, a game-changer in cholesterol management. This in-depth study, designed as a randomized, double-blind, placebo-controlled trial, focused on adults with moderate hypercholesterolemia. Over 12 weeks, it evaluated the effects of different doses of BBR4401, a parabiotic derived from Bifidobacterium breve, agains a placebo.

    Discovering the Results
    The study's remarkable findings showcased significant reductions in LDL-cholesterol levels among participants receiving BBR4401, highlighting its efficacy. Furthermore, the careful assessment of BBR4401's safety and tolerability confirms its potential as a reliable and innovative solution for cholesterol management.

    Ready to find out more?

    Drop us a line today for a free quote!
    (844) 410-1400 - Toll Free